Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 1/2 6Phase 2 4Phase 1 3

Status

Completed 3Terminated 2Recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Brain Neoplasms 12Lung Neoplasms 8Neoplasm Metastasis 7Pancreatic Neoplasms 6Liver Neoplasms 6Glioblastoma 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Hepatocellular 5Prostatic Neoplasms 4Melanoma 4Carcinoma, Renal Cell 4Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Ovarian Neoplasms 2Neurologic Manifestations 2Glioma 2Colorectal Neoplasms 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor 1Stomach Neoplasms 1Spinal Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1

Interventions

Sorafenib 7Radiosurgery 6Bevacizumab 6pembrolizumab 4Oxaliplatin 4Cryosurgery 4atezolizumab 3Radiotherapy, Conformal 3Nivolumab 3Ipilimumab 3Fluorouracil 3Cyclophosphamide 3tremelimumab 2spartalizumab 2lenvatinib 2fludarabine 2Leucovorin 2Injections 2Gemcitabine 2Everolimus 2Epirubicin 2Doxorubicin 2Celecoxib 2Carboplatin 2Capecitabine 2yttrium chloride 1vofatamab 1toripalimab 1tocilizumab 1sapanisertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Liver Neoplasms × Radiosurgery × Clear all
NCT04785287 2026-03-03

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

M.D. Anderson Cancer Center

Phase 1/2 Terminated
13 enrolled
EndocrineGastrointestinalThoracic

Adrenal Gland Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT06725121 2024-12-16

MacroTrans

University Health Network, Toronto

Phase 1/2 Recruiting
48 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02721056 2021-05-10

NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers

Nanobiotix

Phase 1/2 Terminated
23 enrolled
Gastrointestinal

Liver Neoplasms

NCT00152906 2020-08-14

Stereotactic Radiotherapy (SRT) Liver (COLD 1)

University Health Network, Toronto

Phase 1/2 Completed
140 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis

NCT00777894 2019-05-15

Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Swiss Cancer Institute

Phase 1/2 Completed
18 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00178243 2006-09-08

Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation

University of Rochester

Phase 1/2 Completed
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡